# Endothelial Beta 1-integrins in Cerebral Vascular Barrier Integrity > **NIH NIH R01** · UNIVERSITY OF WASHINGTON · 2020 · $547,674 ## Abstract Ischemic stroke acutely targets the cerebral microvasculature. Within hours following proximal MCA occlusion, the microvessel endothelial permeability barrier opens causing “vasogenic” edema in the corpus striatum. This process is not fully understood and has no treatment currently. Cerebral microvessel structure and signaling appears central to these acute changes. Interfering with the established adhesion of endothelial cell β1- integrins to the underlying matrix acutely increases T2 but not ADC by 14T MRI within 6 hours, and acutely increases permeability in vitro, alters tight junction (TJ) expression, and alters F-actin conformation, without loss of endothelial cell viability. However, inhibition of myosin light chain (MLC) phosphorylation, within 6 hours in vitro, prevents the permeability increase when established β1-integrin–matrix adhesion is disrupted. Hence, modulating endothelial β1-integrin signaling acutely could preserve the barrier and decrease striatal edema. The hypotheses to be tested in this proposal state that i) interactions of microvessel endothelial cells with their basal lamina matrix proteins through β1-integrin adhesion receptors are a major structural and signaling determinant of blood-brain barrier behavior, ii) focal ischemia disrupts stable β1-integrin–matrix interactions, iii) disruption of these interactions increases microvessel permeability, and iv) this acutely increased permeability and edema can be prevented by inhibiting β1-integrin signaling. The three Specific Aims will demonstrate that: 1) rapid modulation of the MLC and associated β1-integrin signaling can prevent the acute permeability increase caused by interference with β1-integrin–matrix adhesion, 2) experimental ischemia disrupts endothelial cell β1-integrin–matrix adhesion, induces endothelial signaling that increases permeability, and this can be prevented, and 3) focal ischemia, through tissue injury, decreases β1-integrin expression or matrix adhesion, and increases endothelial permeability, which can be prevented. A central role for endothelial cell β1-integrin–matrix adhesion as the determinant of acute “vasogenic” edema in focal ischemia is conceptually novel and testable. With high-quality primary cerebral endothelial cell cultures from wild type and conditional endothelial β1-integrin knockout constructs to define β1-integrin signaling events (Specific Aim 1), in vitro models to quantify the effects of ischemia on endothelial cell β1-integrin signaling (Specific Aim 2), and real- time assessment of acute edema formation in murine stereotaxic injection and MCA occlusion models using real-time 14T MRI to guide acute assessments of permeability and its prevention with signaling inhibitors (Specific Aims 1 and 3), this Project will demonstrate that β1-integrin–matrix adhesion is pivotal to edema prevention. These very feasible studies are a new direction in stroke research that will substantially further our understanding of acute blood-brain b... ## Key facts - **NIH application ID:** 10118345 - **Project number:** 1R01NS113393-01A1 - **Recipient organization:** UNIVERSITY OF WASHINGTON - **Principal Investigator:** Gregory J Del Zoppo - **Activity code:** R01 (R01, R21, SBIR, etc.) - **Funding institute:** NIH - **Fiscal year:** 2020 - **Award amount:** $547,674 - **Award type:** 1 - **Project period:** 2020-09-30 → 2024-07-31 ## Primary source NIH RePORTER: https://reporter.nih.gov/project-details/10118345 ## Citation > US National Institutes of Health, RePORTER application 10118345, Endothelial Beta 1-integrins in Cerebral Vascular Barrier Integrity (1R01NS113393-01A1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10118345. Licensed CC0. --- *[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*